14,659 Shares in Iradimed Corporation (NASDAQ:IRMD) Bought by Albert D Mason Inc.

Albert D Mason Inc. purchased a new position in shares of Iradimed Corporation (NASDAQ:IRMD - Free Report) during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 14,659 shares of the medical equipment provider's stock, valued at approximately $737,000. Albert D Mason Inc. owned 0.12% of Iradimed at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently bought and sold shares of IRMD. Shaker Investments LLC OH increased its stake in shares of Iradimed by 1.7% during the second quarter. Shaker Investments LLC OH now owns 20,605 shares of the medical equipment provider's stock worth $905,000 after buying an additional 347 shares during the period. ClariVest Asset Management LLC increased its stake in shares of Iradimed by 2.9% during the second quarter. ClariVest Asset Management LLC now owns 17,666 shares of the medical equipment provider's stock worth $776,000 after buying an additional 494 shares during the period. Cim LLC increased its stake in shares of Iradimed by 5.9% during the second quarter. Cim LLC now owns 10,089 shares of the medical equipment provider's stock worth $464,000 after buying an additional 561 shares during the period. Kings Path Partners LLC increased its stake in Iradimed by 2.3% in the third quarter. Kings Path Partners LLC now owns 24,570 shares of the medical equipment provider's stock valued at $1,236,000 after purchasing an additional 562 shares during the last quarter. Finally, 1620 Investment Advisors Inc. purchased a new position in Iradimed in the second quarter valued at approximately $25,000. 92.34% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Separately, Roth Mkm dropped their price target on shares of Iradimed from $65.00 to $60.00 and set a "buy" rating on the stock in a research note on Friday, August 2nd.

Iradimed Stock Down 0.9 %

Iradimed stock traded down $0.46 during mid-day trading on Wednesday, hitting $50.49. The company had a trading volume of 24,989 shares, compared to its average volume of 49,656. The stock has a market cap of $639.41 million, a price-to-earnings ratio of 35.99 and a beta of 0.79. Iradimed Corporation has a 1 year low of $38.53 and a 1 year high of $52.45. The business has a fifty day moving average of $48.00 and a 200 day moving average of $45.06.

Iradimed (NASDAQ:IRMD - Get Free Report) last posted its quarterly earnings data on Thursday, August 1st. The medical equipment provider reported $0.38 earnings per share for the quarter, beating the consensus estimate of $0.33 by $0.05. The business had revenue of $17.93 million during the quarter, compared to the consensus estimate of $17.70 million. Iradimed had a return on equity of 24.71% and a net margin of 26.83%. During the same period in the prior year, the company earned $0.33 earnings per share. Equities analysts anticipate that Iradimed Corporation will post 1.41 earnings per share for the current year.

Iradimed Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, August 30th. Stockholders of record on Tuesday, August 20th were issued a $0.15 dividend. This represents a $0.60 annualized dividend and a dividend yield of 1.19%. The ex-dividend date of this dividend was Tuesday, August 20th. Iradimed's payout ratio is currently 42.55%.

Iradimed Company Profile

IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices and related accessories, and disposables and services in the United States and internationally. It offers MRidium MRI compatible intravenous (IV) infusion pump system with associated disposable IV tubing sets; MRI compatible patient vital signs monitoring system; and 3600 FMD1 with RALU ferromagnetic detection device.